[Acute coronary syndrome in the elderly. Optimal revascularisation strategies]
1Klinik für Kardiologie und Angiologie, Augusta-Kranken-Anstalt Bochum, Bergstrasse 26, Bochum, Germany. m.wehr@augusta-bochum.de
Insights
Elderly patients with acute coronary syndromes often miss life-saving treatments due to fears of adverse effects. Early revascularization significantly benefits older individuals, improving outcomes despite higher complication risks.
Area of Science:
- Cardiology
- Geriatric Medicine
- Internal Medicine
Context:
- Acute coronary syndromes (ACS) and ST-segment elevation myocardial infarction (STEMI) have established treatment guidelines.
- Elderly patients present unique challenges in treatment decision-making due to comorbidities and fear of adverse effects.
Purpose:
- To critically examine the evidence for medical and revascularization therapies in elderly patients with ACS.
- To address the underutilization of potentially life-saving treatments in older populations.
Summary:
- Many elderly patients with ACS do not receive timely percutaneous coronary intervention or thrombolytic therapy.
- Delayed or withheld revascularization in the elderly can lead to irreversible myocardial damage.
- Evidence indicates substantial benefits and improved outcomes for older patients receiving early ACS treatments, despite increased complication risks.
Impact:
- Highlights the need for evidence-based treatment strategies tailored to the elderly population with ACS.
- Encourages the adoption of timely and appropriate revascularization therapies in older adults.
- Aims to improve clinical outcomes and reduce mortality in elderly patients experiencing acute coronary events.
Abstract:
Although there are accepted guidelines for treatment of acute coronary syndromes and ST-segment elevation myocardial infarction, elderly patients may have a variety of conditions that can complicate the decision making process about the best therapy. For fear of adverse effects many elderly patients do not receive potentially lifesaving treatments, such as percutaneous coronary intervention or thrombolytic therapy. Appropriate revascularisation therapy also often will be received too late in the course of the infarct, when irreversible myocardial damage has occurred. Many studies, however, show that older patients will benefit substantially from these therapies and early treatment improves outcome in this population, despite a higher risk of complications. In this review, the evidence regarding medical and revascularisation therapies in acute coronary syndromes in the elderly is critically examined.
Related Concept Videos
Acute Coronary Syndrome IV: Interprofessional Care
Coronary Artery Disease V: Interprofessional Care
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome V: Nursing Management
Angina IV: Management
Atherosclerosis III: Management

